Biotech

Latest Articles

Cassava spends $40M over supposedly misleading Alzheimer's improve

.Cassava Sciences has accepted to pay $40 thousand to fix an investigation into claims it created co...

Merck bags choices on Evaxion's AI-designed vaccine candidates

.Merck &amp Co. has actually grabbed choices on two Evaxion Biotech vaccination candidates, paying o...

Enanta's RSV antiviral crushes popular bunch in obstacle study

.Enanta Pharmaceuticals has connected its own breathing syncytial infection (RSV) antiviral to notab...

Biogen cans SAGE-324 partnership after essential shake neglect

.Biogen has actually carried out the final rites to its own cooperation along with Sage Therapies on...

AbbVie Parkinson's medication from $8.7 B Cerevel purchase ratings

.On the exact same day that some Parkinson's illness medicines are actually being actually called in...

Arch finalizes $3B-plus fund to nurture biopharma startups

.On the heels of a $3 billion fund from Bain Resources Life Sciences, Arc Venture Partners is actual...

Orion to use Aitia's 'digital doubles' to locate brand new cancer drugs

.Finnish biotech Orion has actually spied possible in Aitia's "electronic twin" specialist to develo...

Windtree's surprise med raises high blood pressure in latest period 2 succeed

.While Windtree Therapies has strained to increase the financial origins needed to have to endure, a...

2 cancer biotechs combine, making worldwide footprint

.OncoC4 is actually taking AcroImmune-- as well as its in-house professional production capacities--...

Amgen reports initial period 3 win for $400M eczema drug

.Amgen has shared (PDF) the 1st period 3 records on its own $400 million dermatitis drug, linking th...

Biogen, UCB record phase 3 lupus gain after stopping working earlier trial

.Biogen and also UCB's bet one's bottom dollar improving right into stage 3 astride a failed researc...

Aptadir wishes brand-new RNA preventions can easily turn around difficult cancers

.Italian biotech Aptadir Rehabs has released along with the commitment that its pipeline of preclini...

Wave surfs DMD results to regulatory authorities' doors, sending stockpile

.Surge Lifestyle Sciences has met its goal in a Duchenne muscle dystrophy (DMD) research, placing it...

Sanofi picks brand new CSO from in-stealth biotech

.After a few years in biotech, Mike Quigley, Ph.D., is coming back to the pharma crease, taking up t...

Achilles drops tissue therapy system, supports for cutbacks after missing 'business viability' objectives

.Achilles Therapies has shreded its own tactic. The English biotech is actually stopping work on its...

Aligos trumpets phase 2 MASH succeed, reducing liver fat around 46%

.Aligos Therapies is actually heralding a midstage succeed in metabolic-dysfunction connected steato...

Basilea scores $268M BARDA financing for antifungals, anti-biotics

.Basilea Pharmaceutica's job developing brand new antifungals has received a considerable boost from...

Capricor offers Europe liberties to late-stage DMD therapy for $35M

.Possessing already scooped up the united state legal rights to Capricor Therapies' late-stage Duche...

FDA scraps adcomm for Applied's rare ailment medication

.After dismissing the choice meeting for Applied Therapies' metabolic disorder medication govorestat...

Novo inks $600M NanoVation deal to examine genetic drugs ex-liver

.Novo Nordisk is continuing its own press right into genetic medications, consenting to compensate N...